19 October 2026
strategyland.uk
Cranswick PLC (CWK)
Rank #123 of 280 - Consumer Non-Cyclicals - UK Equities
Cranswick PLC
Factor Analysis Summary
Editorial assessment generated from Cranswick PLC's live factor scores and sector positioning.
Based on Strategyland's proprietary 7-factor analysis, Cranswick PLC (CWK.L) currently holds an overall rank of #123 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.
Key strengths include asset efficiency, where it demonstrates highly efficient capital deployment, converting assets into revenue and returns effectively, and solvency (debt/equity 0.2), where it demonstrates a sound financial footing with manageable debt levels and adequate interest coverage.
Areas requiring attention include valuation (P/E 17.2, dividend yield 391.3%), where the stock appears richly priced on forward earnings and cash flow metrics, as well as technical (RSI 42.7), where bearish technical positioning with price trading below key trend indicators.
Within the Consumer Non-Cyclicals sector, Cranswick PLC sits at composite rank #123, trailing the Consumer Non-Cyclicals peer average (rank 53). It ranks behind all 6 tracked Consumer Non-Cyclicals peers in our model.
The composite profile is weighed down by 4 below-average factor scores, with valuation (rank 249/280) representing the most significant drag on its #123 overall standing.
Strongest Factors
- Asset Efficiency — Rank 6/280 (top quartile)
- Solvency — Rank 93/280 (above average)
- Market Trading — Rank 122/280 (middle of the pack)
Weakest Factors
- Valuation — Rank 249/280 (below average)
- Technical — Rank 247/280 (below average)
Score Analysis
Cranswick PLC is ranked #123 out of 280 UK stocks. Lower factor scores indicate better performance in that category.
Factor Breakdown
1. Liquidity
Score: 194/280How liquid is CWK and can it meet its short-term obligations?
Key Liquidity Metrics
Overall Liquidity Rank
2. Valuation
Score: 249/280Is CWK undervalued compared to its peers and fair value metrics?
Key Valuation Metrics
Dividend
CWK pays a dividend yield of 391.34%.
Dividend Per Share Forecast
3. Profitability
Score: 174/280How profitable is CWK relative to its peers?
EPS Growth
4. Solvency
Score: 93/280How strong is CWK's balance sheet and financial position?
Key Solvency Metrics
Altman Z-Score
5. Asset Efficiency
Score: 6/280How efficiently does CWK deploy its assets and intellectual capital?
Overall Asset Efficiency Rank
6. Market Trading
Score: 122/280How liquid and actively traded is CWK?
Trading Volume
7. Technical
Score: 247/280What do the technical indicators say about CWK?
RSI (14 Day)
Moving Averages
Risk Metrics
Peer Comparison
How does CWK compare to other Consumer Non-Cyclicals stocks?
Overall Rank Comparison
Factor Score Comparison
Similar Stocks
Other top-ranked stocks in the Consumer Non-Cyclicals sector
LiveCatch Healthcare Events Before the Market Moves
SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.
Methodology Note
The analysis presented for Cranswick PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.
Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.
This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.
© 2026 Strategyland by Khurram. All rights reserved.
